Now accepting early access partners

Validation that moves
at the speed of science.

EVOLV | The Validation Factory

The first AI-native Computer System Validation platform built for GAMP 5, 21 CFR Part 11, and FDA QMSR. Generate compliant URS, automate risk assessment, and govern AI model changes — in minutes, not months.

Request Early Access ▶ Try Live Demo
GAMP 5 21 CFR Part 11 21 CFR Part 820 QMSR ISO 13485:2016 FDA PCCP Guidance Aug 2025 GMP Annex 11 EU GMP

The Problem

CSV validation still runs on
spreadsheets and email chains.

Life sciences teams spend months on documentation that should take days. Regulatory guidance has changed. Most platforms haven't.

📋

Weeks to generate a URS

Requirements written manually in Word, reviewed in meetings, rewritten after audit findings. No regulatory traceability. No version control. Just documents.

⚠️

Regulations change. VMPs don't.

FDA's QMSR replaced the QSR on February 2, 2026. The PCCP final guidance landed August 2025. Most validation plans still cite rules that no longer exist.

🤖

AI in GxP with no governance

Drug interaction predictors and defect classifiers are being deployed with no PCCP, no change control, no audit trail. FDA inspectors are starting to notice.

The Platform

One platform.
The entire validation lifecycle.

From first requirement to post-market governance — every step compliant, auditable, and powered by AI that knows GAMP 5.

📄

Validation Factory

Generate GAMP 5-compliant URS from plain English. SMART refinement, PCCP verification, UR/FR decomposition, CSA test scripts, and PDF export with e-signature — in one guided workflow. What took days takes minutes.

URS Generation SMART Refinement UR/FR Decomposition CSA Test Scripts PDF + E-Signature
🔄

Change Control

ServiceNow change requests cross-referenced against your system portfolio in real time. GxP classification, GAMP-aware risk calculation using Severity × Occurrence × Detectability, and automatic revalidation flags. No spreadsheet required.

ServiceNow Integration GxP Classification GAMP Risk Matrix Revalidation Flags
🤖

AI Model Governance

Validated AI models treated as GAMP Category 5 assets. PCCP-aware change assessment aligned to FDA final guidance August 2025. Human-in-the-loop approval queue with 21 CFR Part 11 compliant audit trail.

PCCP Assessment HITL Governance FDA Aug 2025 21 CFR Part 11
📊

Portfolio Dashboard

Every system, every site, every phase — one view. RAG status, action items, regulatory due dates. Register new systems with GxP classification and track their full validation journey from plan to monitor. Built for QA Heads and CTOs.

RAG Status System Registry Lifecycle Tracking Multi-Site

See It In Action

Watch EVOLV handle in 4 minutes
what takes your team weeks.

Three real workflows. No voiceover scripts. No slides. Just the platform doing what it's built to do.

Demo 01

Portfolio Dashboard

Your entire validated system landscape — GAMP category, GxP status, risk level, revalidation due dates — in one view. Built for QA Heads and CTOs who need portfolio-wide compliance visibility instantly..

Demo 02

Change Control & GxP Classification

ServiceNow CR received → portfolio cross-reference → GAMP risk calculation → revalidation decision. Automatic.

Demo 03

AI Model Governance

AI model change in a validated system → PCCP assessment → Governance Hub → human-in-the-loop approval → 21 CFR Part 11 audit trail. Built for FDA's final guidance (Aug 2025).

Try the Validation Factory — live, right now.

Generate a real GAMP 5-compliant URS from your own requirement. No login required.

▶ Open Live Demo

Built For

EVOLV speaks the language
of regulated industries.

Whether you're defending a validation package in an inspection or governing 150 systems across 25 sites — EVOLV gives you the records to back it up.

🧪 QA Head · CSV Manager

Stop writing in Word. Start validating.

EVOLV generates, verifies, and manages your entire validation portfolio with a complete audit trail FDA inspectors can review on the spot.

  • URS from plain English in minutes
  • SMART requirements, auto-verified against GAMP 5
  • Full lifecycle tracking — Plan to Monitor
  • Audit-ready PDFs with e-signature

📋 VP Regulatory Affairs

FDA updated the rules. EVOLV already knows.

QMSR is mandatory. PCCP guidance is final. EVOLV cites the right regulations, routes the right changes, and produces the records you need when an inspector walks in.

  • Aligned to FDA PCCP Guidance Aug 18, 2025
  • 21 CFR Part 820 QMSR / ISO 13485:2016
  • SHA-256 tamper-evident audit trail
  • 21 CFR Part 11 electronic records

💻 CTO · CDO

Your AI models are GAMP Cat 5 assets.

EVOLV gives you the governance infrastructure to deploy AI in GxP contexts without regulatory exposure — with a full HITL approval layer and immutable decision records.

  • AI model registry with version history
  • PCCP-aware change assessment
  • Human-in-the-loop governance hub
  • Portfolio-wide RAG visibility

Regulatory Coverage

GAMP 5 (2nd Edition) 21 CFR Part 11 21 CFR Part 820 QMSR ISO 13485:2016 FDA PCCP Guidance Aug 18, 2025 GMP Annex 11 EU GMP GLP ISO 17025 GDPR 21 CFR Part 820.35 QMSR FDA CSA Guidance 2022

Early Access

Join our first cohort of life sciences partners.

We're working with a small group of pharma and biotech companies before general availability. Early access partners get priority onboarding, direct access to the founding team, and founding-tier pricing locked in permanently.

🔒  We'll respond within 1 business day. Your information is never shared.

Finding the Right Pharmaceutical Consultants Near Corona, CA: A Comprehensive Guide

Jan 05, 2026

Understanding the Role of Pharmaceutical Consultants

In the competitive and highly regulated world of pharmaceuticals, finding the right consultants is crucial. Pharmaceutical consultants offer expert advice on regulatory compliance, product development, and market strategies, helping companies navigate complex challenges. Their guidance is often invaluable for businesses looking to innovate while adhering to stringent industry standards.

Consultants typically possess a wealth of experience and specialized knowledge in areas such as clinical trials, drug safety, and quality assurance. By leveraging their expertise, companies can streamline processes, reduce costs, and bring products to market more efficiently.

pharmaceutical consultants

Key Considerations When Choosing a Consultant

When searching for pharmaceutical consultants near Corona, CA, it's essential to consider several factors. First, assess the consultant’s experience and track record. A consultant with a proven history of successful projects in your specific area of need can offer insights that are particularly relevant.

Additionally, consider the scope of services offered. Some consultants may specialize in regulatory affairs, while others focus on product development or marketing strategies. Determine your specific needs and find a consultant whose expertise aligns with those requirements.

Evaluating Credentials and Expertise

Credentials and certifications are crucial indicators of a consultant’s expertise. Look for professionals with relevant qualifications, such as a background in pharmaceutical sciences or certifications from recognized industry bodies. These credentials often reflect a commitment to maintaining high standards of practice.

Moreover, evaluate the consultant’s familiarity with local regulations in California. Understanding state-specific requirements can be a significant advantage, ensuring that your projects comply with all necessary legal frameworks.

consultant meeting

Personalized Approach and Communication

A successful consulting relationship relies heavily on clear communication and a personalized approach. Effective consultants take the time to understand your company’s unique challenges and goals, tailoring their strategies to meet your specific needs. This personalized service can lead to more effective solutions and better outcomes.

Regular updates and open lines of communication are essential for staying informed and making timely decisions. Choose a consultant who prioritizes transparency and is readily available to address your questions and concerns.

Researching Local Options

Finding the right pharmaceutical consultant involves thorough research. Start by seeking recommendations from industry peers or professional networks. Online reviews and testimonials can also provide valuable insights into the experiences of past clients, helping you make an informed choice.

Consider reaching out to local industry associations or attending regional conferences and events in Corona, CA. These platforms can offer opportunities to connect with experienced consultants and learn more about their services.

researching online

Cost Considerations and Value Assessment

While cost is an important factor, it should not be the sole determinant when selecting a consultant. Focus on the value and expertise they bring to your projects. A higher upfront investment in a skilled consultant can lead to long-term savings by avoiding costly mistakes and accelerating project timelines.

Request detailed proposals from potential consultants, outlining their strategies, timelines, and fee structures. This information can help you compare options and choose a consultant who offers the best combination of expertise and value.

Conclusion

Finding the right pharmaceutical consultants near Corona, CA, involves careful consideration of expertise, experience, and communication. By prioritizing these factors, companies can forge successful partnerships that drive innovation and ensure compliance with industry standards. With the right guidance, navigating the complexities of the pharmaceutical industry becomes a more manageable and rewarding endeavor.